Press Releases

Date	Title
August 2, 2023	Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
July 26, 2023	Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
July 17, 2023	Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)
June 27, 2023	Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer
May 3, 2023	Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
April 26, 2023	Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
April 5, 2023	Corcept Therapeutics Announces Final Results of Tender Offer
April 3, 2023	Corcept Therapeutics Announces Preliminary Results of Tender Offer
March 28, 2023	Corcept Therapeutics Initiates CATALYST Clinical Trial
March 6, 2023	Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock